Prospective morbidity and mortality assessment of cytoreductive surgery plus perioperative intraperitoneal chemotherapy to treat peritoneal dissemination of appendiceal mucinous malignancy

Annals of Surgical Oncology

Volumn 13, Issue 5, 2006, Pages 635-644

  Sugarbaker, Paul H ^a   Alderman, Robert ^a   Edwards, Gary ^a   Marquardt, Christina Ellen ^a   Gushchin, Vadim ^a   Esquivel, Jesus ^a   Chang, David ^b  

^a WASHINGTON CANCER INSTITUTE   (United States)

^b WESTAT   (United States)

Author keywords

5 Fluorouracil; Cytoreductive surgery; Hyperthermia; Intraperitoneal chemotherapy; Mitomycin C; Peritonectomy

Indexed keywords

FLUOROURACIL; HEPARIN; MITOMYCIN C;

ABDOMINAL INFECTION; ABNORMALLY LOW SUBSTRATE CONCENTRATION IN BLOOD; ABSCESS; ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; AGED; ANALYTIC METHOD; ANASTOMOSIS LEAKAGE; APPENDIX TUMOR; ARTICLE; ASCITES; BILE LEAKAGE; CANCER CHEMOTHERAPY; CANCER MORTALITY; CARDIOTOXICITY; CAUSE OF DEATH; CHEMOTHERAPY INDUCED EMESIS; COMMUNICATION DISORDER; COMPARTMENT SYNDROME; CONTROLLED STUDY; CYTOREDUCTIVE SURGERY; DATA BASE; DEATH; DEEP VEIN THROMBOSIS; DEHYDRATION; DIARRHEA; DIGESTIVE SYSTEM FISTULA; DISORIENTATION; DRUG FATALITY; FASCIITIS; FEMALE; FISTULA; GASTROINTESTINAL TOXICITY; HEART ARRHYTHMIA; HEMATOLOGIC DISEASE; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPERTHERMIC THERAPY; HYPOTENSION; INTELLECTUAL IMPAIRMENT; INTENSIVE CARE UNIT; ISCHEMIA; LUNG EDEMA; LUNG EMBOLISM; LUNG TOXICITY; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; MOUTH PAIN; MOUTH ULCER; NAUSEA AND VOMITING; NEUROTOXICITY; NEUTROPENIA; OPERATING ROOM; PANCREAS FISTULA; PANCREATITIS; PERITONEUM METASTASIS; PNEUMOTHORAX; POSTOPERATIVE COMPLICATION; POSTOPERATIVE HEMORRHAGE; PROSPECTIVE STUDY; RESPIRATORY DISTRESS; SCORING SYSTEM; SEPSIS; SIDE EFFECT; STROKE; THROMBOCYTOPENIA; THROMBOPHLEBITIS; THROMBOSIS; TOTAL PARENTERAL NUTRITION; URINARY TRACT INFECTION; URINE INCONTINENCE; VEIN THROMBOSIS; WOUND INFECTION;

ADENOCARCINOMA, MUCINOUS; ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; APPENDICEAL NEOPLASMS; COMBINED MODALITY THERAPY; DISEASE PROGRESSION; FEMALE; FLUOROURACIL; HUMANS; HYPERTHERMIA, INDUCED; MALE; MIDDLE AGED; MITOMYCIN; PATIENT SELECTION; PERITONEAL NEOPLASMS; PROGNOSIS; PROSPECTIVE STUDIES; REOPERATION; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 33645865266     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/ASO.2006.03.079     Document Type: Article

References (36)

1. Gough DB, Donohue JH, Schutt AJ, et al. Pseudomyxoma peritonei. Long-term patient survival with an aggressive regional approach. Ann Surg Oncol 1994; 219:112-9.
2. Misdraji J, Yantiss RK, Graeme-Cook FM, Balis UJ, Young RH. Appendiceal mucinous neoplasms. A clinicopathological analysis of 107 cases. Am J Surg Pathol 2003; 27:1089-103.
3. Miner TJ, Shia J, Jaques DP, Klimstra DS, Brennan MF, Coit DG. Long-term survival following treatment of pseudomyxoma peritonei. An analysis of surgical therapy. Ann Surg 2005; 241:300-8.
4. Sugarbaker PH. Results of treatment of 385 patients with peritoneal surface spread of appendiceal malignancy. Ann Surg Oncol 1999; 6:727-31.
5. Shen P, Levine EA, Hall J. et al. Factors predicting survival after intraperitoneal hyperthermic chemotherapy with mitomycin C after cytoreductive surgery for patients with peritoneal carcinomatosis. Arch Surg 2003; 138:26-33.
6. van Ruth S, Acherman YIZ, van de Vijver MJ, Hart AAM, Verwaal VJ, Zoetmulder FAN. Pseudomyxoma peritonei: a review of 62 cases. Eur J Surg Oncol 2003; 29:682-8.
7. Deraco M, Baratti D, Inglese MG, et al. Peritonectomy and intraperitoneal hyperthermic perfusion (IPHP): a strategy that has confirmed its efficacy in patients with pseudomyxoma peritonei. Ann Surg Oncol 2004; 11:393-8.
8. Güner Z, Schmidt U, Dahlke MH, Schlitt HJ, Klempnauer J, Piso P. Cytoreductive surgery and intraperitoneal chemotherapy for pseudomyxoma peritonei. Int J Colorectal Dis 2005; 20:155-60.
9. Loungnarath R, Causeret S, Bossard N, et al. Cytoreductive surgery with intraperitoneal chemohyperthermia for the treatment of pseudomyxoma peritonei: a prospective study. Dis Colon Rectum 2005; 48:1372-9.
10. Sugarbaker PH. Peritonectomy procedures. Ann Surg 1995; 221:29-42.
11. De Lima Vazquez V, Sugarbaker PH. Cholecystectomy, lesser omentectomy and stripping of the omental bursa, a peritonectomy procedure. J Surg Oncol 2003; 84:45-9.
12. De Lima Vazquez V, Sugarbaker PH. Total anterior parietal peritonectomy. J Surg Oncol 2003; 83:261-3.
13. Sugarbaker PH. Cytoreduction including total gastrectomy for pseudomyxoma peritonei. Br J Surg 2002; 89:202-12.
14. Sugarbaker PH. Management of Peritoneal Surface Malignancy Using Intraperitoneal Chemotherapy and Cytoreductive Surgery. A Manual for Physicians and Nurses. 3rd ed. Grand Rapids, MI: Ludann Co. 1998.
15. Sugarbaker PH, Averbach AM, Jacquet P, Stephens AD, Stuart OA. A simplified approach to hyperthermic intraoperative intraperitoneal chemotherapy (HIIC) using a self retaining retractor. In: Sugarbaker PH, ed. Peritoneal Carcinomatosis: Principles of Management. Boston: Kluwer, 1996:415-21.
16. Yan H, Pestieau SR, Shmookler BM, Sugarbaker PH. Histopathologic analysis in 46 patients with pseudomyxoma peritonei syndrome: failure vs. success with a second-look operation. Mod Pathol 2001; 14:164-71.
17. Ronnett BM, Shmookler BM, Sugarbaker PH, Kurman RJ. Pseudomyxoma peritonei: new concepts in diagnosis, origin, nomenclature, relationship to mucinous borderline (low malignant potential) tumors of the ovary. In: Fechner RE, Rosen PP, eds. Anatomic Pathology. Chicago: ASCP Press, 1997:197-226.
18. Sugarbaker PH. Successful management of microscopic residual disease in large bowel cancer. Cancer Chemother Pharmacol 1999; 43(Suppl):S15-25.
19. Schnake KJ, Sugarbaker PH, Yoo D. Neutropenia following perioperative intraperitoneal chemotherapy. Tumori 1999; 85:41-6.
20. Sugarbaker PH, Kern K, Lack E. Malignant pseudomyxoma of colonic origin. Natural history and presentation of a curative approach to treatment. Dis Colon Rectum 1987; 30:772-9.
21. Sugarbaker PH, Jablonski KA. Prognostic features of 51 colorectal and 130 appendiceal cancer patients with peritoneal carcinomatosis treated by cytoreductive surgery and intraperitoneal chemotherapy. Ann Surg 1995; 221:124-32.
22. Murio JE, Sugarbaker PH. Gastrointestinal fistula following cytoreductive procedures for peritoneal carcinomatosis: incidence and outcome. J Exp Clin Cancer Res 1993; 3:153-8.
23. Fernandez-Trigo V, Sugarbaker PH. Diagnosis and management of postoperative gastrointestinal fistulas: a kinetic analysis. J Exp Clin Cancer Res 1994; 13:233-41.
24. Esquivel J, Vidal-Jove J, Steves MA, Sugarbaker PH. Morbidity and mortality of cytoreductive surgery and intraperitoneal chemotherapy. Surgery 1993; 113:631-6.
25. Jacquet P, Stephens AD, Averbach AM, et al. Analysis of morbidity and mortality in 60 patients with peritoneal carcinomatosis treated by cytoreductive surgery and heated intraoperative intraperitoneal chemotherapy. Cancer 1996; 77:2622-9.
26. Stephens AD, Alderman R, Chang D, et al. Morbidity and mortality of 200 treatments with cytoreductive surgery and hyperthermic intraoperative intraperitoneal chemotherapy using the Coliseum technique. Ann Surg Oncol 1999; 6:790-6.
27. Sugarbaker PH, Welch L, Mohamed F, Glehen O. A review of peritoneal mesothelioma at the Washington Cancer Institute. Surg Oncol Clin North Am 2003; 12:605-21.
28. Elias D, Blot F, Et Otmany A, et al. Curative treatment of peritoneal carcinomatosis arising from colorectal cancer by complete resection and intraperitoneal chemotherapy. Cancer 2001; 92:71-6.
29. Butterworth SA, Panton ONM, Klaassen DJ, Shah AM, McGregor GI. Morbidity and mortality associated with intraperitoneal chemotherapy for pseudomyxoma peritonei. Am J Surg 2002; 183:529-32.
30. Glehen O, Osinsky D, Cotte E, et al. Intraperitoneal chemohyperthermia using a closed abdominal procedure and cytoreductive surgery for the treatment of peritoneal carcinomatosis: morbidity and mortality analysis of 216 consecutive procedures. Ann Surg Oncol 2003; 10:863-9.
31. Pilati P, Mocellin S, Rossi CR, et al. Cytoreductive surgery combined with hyperthermic intraoperative intraperitoneal chemotherapy for peritoneal carcinomatosis arising from colon adenocarcinoma. Ann Surg Oncol 2003; 10:508-13.
32. Shen P, Hawksworth J, Lovato J, et al. Cytoreductive surgery and intraperitoneal hyperthermic chemotherapy with mitomycin C for peritoneal carcinomatosis from nonappendiceal colorectal carcinoma. Ann Surg Oncol 2004; 11:178-86.
33. Ahmad SA, Kim J, Sussman JJ, et al. Reduced morbidity following cytoreductive surgery and intraperitoneal hyperthermic chemoperfusion. Ann Surg Oncol 2004; 11:387-92.
34. Verwaal VJ, van Tinteren H, Ruth SV, Zoetmulder FAN. Toxicity of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. J Surg Oncol 2004; 85:61-7.
35. Schmidt U, Dahlke MH, Klempnauer J, Schlitt HJ, Piso P. Perioperative morbidity and quality of life in long-term survivors following cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Eur J Surg Oncol 2005; 31:53-8.
36. Kusamura S, Younan R, Baratti D, Costanzo P, Favaro M, Gavazzi C, Deraco M. Cytoreductive surgery followed by intraperitoneal hyperthermic perfusion. Analysis of morbidity and mortality in 209 peritoneal surface malignancies treated with closed abdomen technique. Cancer 2006; 106:1144-53.